Ditchcarbon
  • Customers
  1. Organizations
  2. Orion
Public Profile
Pharmaceutical Preparation Manufacturing
FI
updated a month ago

Orion

Company website

Orion Corporation, commonly referred to as Orion, is a Finnish pharmaceutical company headquartered in Espoo, Finland. Founded in 1917, Orion has established itself as a key player in the pharmaceutical and biotechnology industry, with a strong presence in Europe and beyond. The company focuses on developing innovative medicines and diagnostic products, particularly in the fields of oncology, pain management, and central nervous system disorders. Orion's core offerings include prescription pharmaceuticals and over-the-counter products, distinguished by their commitment to quality and research-driven development. With a robust pipeline of new therapies and a reputation for excellence, Orion has achieved notable milestones, including successful collaborations and a growing international market presence. As a trusted name in healthcare, Orion continues to advance its mission of improving patient outcomes through science and innovation.

DitchCarbon Score

How does Orion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

69

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Orion's score of 69 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

83%

Let us know if this data was useful to you

Orion's reported carbon emissions

In 2024, Orion Corporation reported total greenhouse gas emissions of approximately 371,000,000 kg CO2e, comprising 5,625,000 kg CO2e from Scope 1, 5,330,000 kg CO2e from Scope 2 (market-based), and a significant 361,961,000 kg CO2e from Scope 3 emissions. The Scope 3 emissions include substantial contributions from purchased goods and services (about 277,588,000 kg CO2e) and upstream transportation and distribution (approximately 25,426,000 kg CO2e). Orion has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 75% by 2025, using 2016 as the baseline year. This target is part of a broader strategy to achieve net-zero emissions by 2050. Additionally, the company has committed to reducing its absolute Scope 1 and 2 emissions by 70% by 2030 from a 2023 base year, as part of its Science Based Targets initiative (SBTi) commitments. Furthermore, Orion aims for 78% of its suppliers, covering emissions from purchased goods and services, capital goods, and upstream transportation and distribution, to have science-based targets by 2029. Overall, Orion's emissions data and climate commitments reflect a proactive approach to sustainability, aligning with industry standards and global climate goals.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

200720082009201320142015201620172018201920202021202220232024
Scope 1
3,740,000
0,000,000
0,000,000
-
0,000,000
000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
21,685,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
0,000,000
0,000,000
Scope 3
-
-
-
-
-
-
-
-
-
-
-
000,000,000
-
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Orion's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Orion is in FI, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Orion is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

RECORDATI

LU
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Vernalis Limited

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Pharma Mar

ES
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Faes Farma

ES
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Consort Medical plc

GB
•
Health and social work services (85)
Updated 9 days ago

Indivior

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250827.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy